Cargando…

Tolvaptan for water retention in heart failure: a systematic review

OBJECTIVE: The purpose of this systematic review is to collect, appraise, and synthesize existing evidence from systematic reviews and meta-analyses (SRs/MAs) on the effectiveness of tolvaptan for water retention in heart failure. METHODS: A comprehensive literature search was performed on PubMed, E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yujing, Li, Haoyang, Gao, Jin, Mi, Zishuo, Chen, Hao, Li, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386224/ https://www.ncbi.nlm.nih.gov/pubmed/37516894 http://dx.doi.org/10.1186/s13643-023-02293-3

Ejemplares similares

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

Network Pharmacology Study on Molecular Mechanisms of Zhishi Xiebai Guizhi Decoction in the Treatment of Coronary Heart Disease
por: Gao, Jin, et al.
Publicado: (2021)

Tolvaptan in reversing worsening acute heart failure: A systematic review and meta-analysis
por: Wang, Lili, et al.
Publicado: (2019)

Tolvaptan add‐on therapy in patients with acute heart failure: A systematic review and meta‐analysis
por: Luo, Xiandu, et al.
Publicado: (2020)

Hemodynamic and Hormonal Effects of Tolvaptan for Heart Failure
por: Kiuchi, Shunsuke, et al.
Publicado: (2018)

Effects of Tolvaptan in patients with acute heart failure: a systematic review and meta-analysis
por: Wang, Chunbin, et al.
Publicado: (2017)

Efficacy of tolvaptan for chronic heart failure: Study protocol for a systematic review of randomized controlled trial
por: Gao, Wei-qin, et al.
Publicado: (2019)

Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis
por: Wu, Mei-Yi, et al.
Publicado: (2017)

Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016)

Long-Term Tolvaptan Treatment in Refractory Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2019)

Correction: Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis
por: Wu, Mei-Yi, et al.
Publicado: (2019)

Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients
por: Nodari, Savina, et al.
Publicado: (2010)

The efficacy of tolvaptan for heart failure in chronic kidney disease: A protocol for systematic review and meta-analysis
por: Zhu, Zhi-Yong, et al.
Publicado: (2022)

Dual Impact of Tolvaptan on Intracellular and Extracellular Water in Chronic Kidney Disease Patients with Fluid Retention
por: Masuda, Takahiro, et al.
Publicado: (2016)

Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome
por: Aghel, Arash, et al.
Publicado: (2008)

Effects of tolvaptan in patients with chronic kidney disease and chronic heart failure
por: Katsumata, Mari, et al.
Publicado: (2017)

Renoprotective effect of tolvaptan in patients with new‐onset acute heart failure
por: Kin, Hiromi, et al.
Publicado: (2020)

Predictors of in-hospital mortality in elderly patients with heart failure treated with tolvaptan
por: Kobayashi, Masakazu, et al.
Publicado: (2023)

Long-term effects of tolvaptan in patients requiring recurrent hospitalization for heart failure
por: Ogawa, Hayato, et al.
Publicado: (2015)

Effects of tolvaptan on urine output in hospitalized heart failure patients with hypoalbuminemia or proteinuria
por: Takagi, Koji, et al.
Publicado: (2017)

Early Initiation of Tolvaptan is Associated with Early Discharge in Elderly Heart Failure Patients
por: Kiuchi, Shunsuke, et al.
Publicado: (2021)

Temporal Change in Renoprotective Effect of Tolvaptan on Patients with Heart Failure: AURORA Study
por: Nishino, Masami, et al.
Publicado: (2022)

Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia
por: Oka, Tatsufumi, et al.
Publicado: (2021)

Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014)

Hypernatremia induced by low-dose Tolvaptan in a Patient with refractory heart failure: A case report
por: Li, Tian, et al.
Publicado: (2019)

The effects of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failure
por: Otsuka, Tomoyuki, et al.
Publicado: (2013)

Echocardiographic characteristics of patients with acute heart failure requiring tolvaptan: a retrospective study
por: Nakada, Yasuki, et al.
Publicado: (2015)

Long-Term Effects and Prognosis in Acute Heart Failure Treated with Tolvaptan: The AVCMA Trial
por: Suzuki, Satoshi, et al.
Publicado: (2014)

Impact of chronic kidney disease on the diuretic response of tolvaptan in acute decompensated heart failure
por: Ikeda, Shuntaro, et al.
Publicado: (2017)

A case report with shock induced by tolvaptan in an elderly patient with congestive heart failure
por: Zhang, Zhi-gang, et al.
Publicado: (2018)

Impact of renal function on mid-term outcomes in heart failure patients treated with tolvaptan
por: Fujioka, Kensuke, et al.
Publicado: (2019)

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction
por: Matsue, Yuya, et al.
Publicado: (2017)

Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction
por: Tamaki, Shunsuke, et al.
Publicado: (2020)

Temporal trends in tolvaptan use after revision of national heart failure guidelines in Japan
por: Yamazaki, Yusuke, et al.
Publicado: (2021)

Early initiation of tolvaptan is associated with early discharge in patients with heart failure regardless of age
por: Kiuchi, Shunsuke, et al.
Publicado: (2022)

Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart Failure
por: Okada, Tomoaki, et al.
Publicado: (2023)

Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis
por: Yin, Cong, et al.
Publicado: (2023)

Acute heart failure volume control multicenter randomized (AVCMA) trial: Comparison of tolvaptan and carperitide
por: Suzuki, Satoshi, et al.
Publicado: (2013)

Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure
por: Jujo, Kentaro, et al.
Publicado: (2016)

Clinical utility of early use of tolvaptan in very elderly patients with acute decompensated heart failure
por: Niikura, Hiroki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9ki7kv1gmdu2js3091vcrgolpf